NP39726 Generic and Biosimilar Cancer Medicines
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £197,026,942 |
|---|---|
| Status | active |
| Category (CPV) | 33600000 |
| Region | Scotland |
| Deadline | 26 Aug 2026 |
| Procedure | open |
| OCID | ocds-h6vhtk-06d3b5 |
description
Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.
documents
- NP39726 Generic and Biosimilar Cancer Medicines , contractNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 24 Jul 2026 | Contract notice (F02) | Earlier regulations | 070486-2026 |
more from The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- PSD19026 Pulsant Data Centres · £67,828 · 28 Jul 2026
- Multi Modality Imaging Framework - mammography call off · £743,550 · 24 Jul 2026
- Courier Services · £2,047,500 · 24 Jul 2026
- Targeted Lung Cancer Screening · 24 Jul 2026
- Purchase of Orthopaedic Power Tools, Bone Cement & Mixers, Pulse Lavage & Tourniquets · £40,000,000 · 23 Jul 2026
- NP646 Haemostatic & Coagulation Products · £15,000,000 · 20 Jul 2026
- C002022 Provision of a virtual platform to support the Public Services Delivery Scotland annual conference · £150,000 · 17 Jul 2026
- vCreate Software Licenses - NICU and PICU · £70,737 · 9 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Public Contracts Scotland. Contact details for named individuals are not reproduced on this site.